Thomas G. Chu, M.D.

Retina-Vitreous Associates Medical Group

Ophthalmology

Beverly Hills, Los Angeles, North Hollywood, Pasadena, Torrance

Most recent review: 5 days ago New
4.9
212 Ratings
78 Comments

Dr. Thomas Chu, M.D., is an internationally recognized clinician, scientist, and surgeon. He attended Brown University in Rhode Island, where he majored in Biochemistry. He completed his medical training and Doctorate Degree in Biochemistry at Mount Sinai School of Medicine in New York.

4.9
212 Ratings
78 Comments

Dr. Thomas Chu, M.D., is an internationally recognized clinician, scientist, and surgeon. He attended Brown University in Rhode Island, where he majored in Biochemistry. He completed his medical training and Doctorate Degree in Biochemistry at Mount Sinai School of Medicine in New York.

The reviews listed below were collected independently of Retina-Vitreous Associates Medical Group through rater8. Each review represents an authentic and verified patient experience.

very through exam

(5 days ago) May-2026

Dr. Chu is thorough, efficient and proactive and provides excellent eye care!

(2 weeks ago) May-2026

It was a very great experience. He was so thorough, friendly & explained everything clearly to my brother . He used to treat my mother as a patient years ago & he is the same great doctor!!

(1 month ago) Apr-2026

Great service, from everyone in the office and The Doctor

(1 month ago) Apr-2026

Every visit is great with dr. Thomas g chu ..

(2 months ago) Mar-2026

Excellent. Professional. Clearly caring

(2 months ago) Mar-2026

Dr. Chu is fabulous but the wait time is outrageous.

(2 months ago) Mar-2026

He’s very friendly and knows what he’s going!

(2 months ago) Mar-2026

always a professional pleasure

(2 months ago) Mar-2026

Excellent retina surgeon and Dr. Chu is very compassionate to the patients Dr. Chu performed a surgery on me a month ago. Dr. Chu explained to me what to expect from the surgery before and also after the surgery. My surgery went very smooth and the recovery is going very well.

(2 months ago) Mar-2026
Read More